SmileDirectClub Taps Oral Care Industry Veteran Brett Deaver To Lead Its Growing Global Partner Network

3 years ago

NASHVILLE, Tenn., Dec. 06, 2021 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (Nasdaq: SDC), the next generation oral care company with the…

TOMI launches SteraMist Amazon Store featuring the SteraPak SteraPak Leading Disinfection System for All Industries

3 years ago

FREDERICK, Md., Dec. 06, 2021 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), is a global company specializing…

Neuronetics Announces Key Role for NeuroStar Advanced Therapy at 4th International Brain Stimulation Conference

3 years ago

Symposium to Highlight World’s Largest Depression Outcomes RegistryMALVERN, Pa., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a…

Yield10 Bioscience to Participate in the Benzinga Global Small Cap Conference on December 9, 2021

3 years ago

WOBURN, Mass., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announced today that…

PDS Biotech Provides Recruitment update for National Cancer Institute-Led Phase 2 Clinical Trial of PDS0101-Based Combination

3 years ago

Institutional Review Board (IRB) approval has been obtained and clinical trial recruitment resumesFLORHAM PARK, N.J., Dec. 06, 2021 (GLOBE NEWSWIRE)…

Digipath, Inc. to Present at the Emerging Growth Conference on Wednesday, December 8th at 12n EST/ 9:00 am PST

3 years ago

Digipath Invites Individuals and Institutional Investors, as well as Advisors and Analysts, to Attend Its Real-Time, Interactive Presentation at the…

180 Life Sciences Provides Follow-Up Information on Oxford University and the Company’s Successful Dupuytren’s Phase 2b Clinical Trial Results

3 years ago

PALO ALTO, Calif., Dec. 06, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the…

BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public Offering

3 years ago

NEW YORK, Dec. 06, 2021 (GLOBE NEWSWIRE) -- BioPlus Acquisition Corp. (the “Company”) announced today that it priced its upsized…

Pulmocide Receives Investment from the Cystic Fibrosis Foundation

3 years ago

The Cystic Fibrosis Foundation invested $3.5 million in Pulmocide as part of the CF Foundation’s Lung Transplant InitiativeFunding supports prophylaxis…

AGTC Appoints Biopharmaceutical Industry Leader James Robinson to its Board of Directors

3 years ago

Robinson’s expertise in development and commercialization adds to the clinical and commercial experience of newly appointed management teamGAINESVILLE, Fla. and CAMBRIDGE,…